These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17278492)

  • 41. Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer.
    Yuen J; Rodrigues G; Trenka K; Coad T; Yartsev S; D'Souza D; Lock M; Bauman G
    Radiat Oncol; 2008 Jan; 3():1. PubMed ID: 18179695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions.
    Spalding AC; Jee KW; Vineberg K; Jablonowski M; Fraass BA; Pan CC; Lawrence TS; Haken RK; Ben-Josef E
    Med Phys; 2007 Feb; 34(2):521-9. PubMed ID: 17388169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose painting to treat single-lobe prostate cancer with hypofractionated high-dose radiation using targeted external beam radiation: Is it feasible?
    Amini A; Westerly DC; Waxweiler TV; Ryan N; Raben D
    Med Dosim; 2015; 40(3):256-61. PubMed ID: 25824420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simplified intensity-modulated arc therapy for dose escalated prostate cancer radiotherapy.
    Bauman G; Gete E; Chen JZ; Wong E
    Med Dosim; 2004; 29(1):18-25. PubMed ID: 15023389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantification of prostate and seminal vesicle interfraction variation during IMRT.
    Frank SJ; Dong L; Kudchadker RJ; De Crevoisier R; Lee AK; Cheung R; Choi S; O'Daniel J; Tucker SL; Wang H; Kuban DA
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):813-20. PubMed ID: 18207664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improving IMRT delivery efficiency using intensity limits during inverse planning.
    Coselmon MM; Moran JM; Radawski JD; Fraass BA
    Med Phys; 2005 May; 32(5):1234-45. PubMed ID: 15984674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inverse treatment planning by physically constrained minimization of a biological objective function.
    Stavrev P; Hristov D; Warkentin B; Sham E; Stavreva N; Fallone BG
    Med Phys; 2003 Nov; 30(11):2948-58. PubMed ID: 14655942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incorporating organ movements in IMRT treatment planning for prostate cancer: minimizing uncertainties in the inverse planning process.
    Unkelbach J; Oelfke U
    Med Phys; 2005 Aug; 32(8):2471-83. PubMed ID: 16193776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A particle swarm optimization algorithm for beam angle selection in intensity-modulated radiotherapy planning.
    Li Y; Yao D; Yao J; Chen W
    Phys Med Biol; 2005 Aug; 50(15):3491-514. PubMed ID: 16030379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
    Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
    Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Later outcomes and alpha/beta estimate from hypofractionated conformal three-dimensional radiotherapy versus standard fractionation for localized prostate cancer.
    Leborgne F; Fowler J; Leborgne JH; Mezzera J
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1200-7. PubMed ID: 21477933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dosimetric advantages and superior treatment delivery efficiency of RapidArc over conventional intensity-modulated radiotherapy in high-risk prostate cancer involving seminal vesicles and pelvic nodes.
    Poon DM; Kam M; Leung CM; Chau R; Wong S; Lee WY; Wong KC; Yu B; Chan A
    Clin Oncol (R Coll Radiol); 2013 Dec; 25(12):706-12. PubMed ID: 23954261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer.
    Chu W; Loblaw DA; Chan K; Morton G; Choo R; Szumacher E; Danjoux C; Pignol JP; Cheung P
    Radiat Oncol; 2015 Apr; 10():95. PubMed ID: 25903934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dosimetric effects of patient rotational setup errors on prostate IMRT treatments.
    Fu W; Yang Y; Li X; Heron DE; Huq MS; Yue NJ
    Phys Med Biol; 2006 Oct; 51(20):5321-31. PubMed ID: 17019041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IMRT planning on adaptive volume structures--a decisive reduction in computational complexity.
    Scherrer A; Küfer KH; Bortfeld T; Monz M; Alonso F
    Phys Med Biol; 2005 May; 50(9):2033-53. PubMed ID: 15843735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
    Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
    Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
    Portaluri M; Fucilli FI; Castagna R; Bambace S; Pili G; Tramacere F; Russo D; Francavilla MC
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1036-43. PubMed ID: 16750321
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose sculpting with generalized equivalent uniform dose.
    Wu Q; Djajaputra D; Liu HH; Dong L; Mohan R; Wu Y
    Med Phys; 2005 May; 32(5):1387-96. PubMed ID: 15984690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer.
    Hysing LB; Skorpen TN; Alber M; Fjellsbø LB; Helle SI; Muren LP
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1496-503. PubMed ID: 18538493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.